Fundraising FoxWilbe Capital — Full Portfolio
4 tracked investments · listed companies and verified rows first
Cyclana Bio is a biotech company developing therapeutic programs focused on the extracellular matrix and tissue-level disease biology, with a flagship focus on women's health conditions such as endometriosis.
BiotechDeep TechDigital HealthFemTechCambridge, GB
Léa(Co-founder & CEO)inKevin(Co-founder)in
Co-investorsEka VenturesNFX
ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.
AI & Machine LearningBiotechDeep Tech
Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)
Co-investorsBlueYard CapitalHAWKTAILOctopus VenturesAcequia Capital (AceCap)Amino Collectiveredalpine
Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
AI & Machine LearningBiotechHealthtechMedical DevicesOxford, GB
Jonathan Kwok(Co-Founder, President & Chief Medical Officer)inLian Ni Lee(VP Preclinical & Co-Founder)in
Co-investorsAmplify PartnersManta Ray VenturesOctopus VenturesEMV CapitalKindred CapitalMartlet Capital+1 more
Milvus Advanced is a deeptech company that designs and manufactures high-performance nanomaterials and nanoalloys from abundant raw materials as replacements for scarce materials such as platinum-group metals.
Advanced ManufacturingCleantechDeep TechNew MaterialsOxford, GB
Assia Kasdi(Founder)in
Co-investorsHoxton VenturesLowercarbon CapitalÜbermorgen VenturesUnruly CapitalAcequia Capital OriginEQT Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.